Chronic Total Occlusion Registry
- Conditions
- Coronary StenosisCoronary OcclusionCoronary Artery Stenosis
- Interventions
- Procedure: Percutaneous coronary interventionProcedure: Coronary Artery Bypass GraftingDrug: Medical treatment
- Registration Number
- NCT04041921
- Lead Sponsor
- Seung-Jung Park
- Brief Summary
This study evaluated the long-term outcome of patients with chronic total occlusion treated with percutaneous coronary intervention, medical treatment or coronary artery bypass grafting.
- Detailed Description
This study is connected with Decision-CTO trial(NCT01078051). Randomized subjects and registry group subjects from Decision-CTO trial continue 10 years follow-up on this study.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 4006
- Patients with angina or silent ischemia and documented ischemia
- Patients with De novo chronic coronary occlusion ≥ 3months and reference diameter ≥ 2.5 mm on coronary angiography
- Age > 18 years
- Refuse to participate in this study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Chronic coronary occlusion patients Percutaneous coronary intervention ≥3 months chronic total occlusion on coronary angiography Chronic coronary occlusion patients Coronary Artery Bypass Grafting ≥3 months chronic total occlusion on coronary angiography Chronic coronary occlusion patients Medical treatment ≥3 months chronic total occlusion on coronary angiography
- Primary Outcome Measures
Name Time Method Composite event of all cause death, myocardial infarction, stroke or all kinds of repeat revascularization 10 years
- Secondary Outcome Measures
Name Time Method Event rate of all cause death 10 years Event rate of rehospitalization due to acute coronary syndrome 10 years Event rate of acute myocardial infarction 10 years Event rate of stroke 10 years Event rate of Procedural success 5 days Procedural success is defined as \< 30% final stenosis and the absence of in-hospital event including death, Q-wave myocardial infarction or urgent repeat revascularization.
Event rate of repeat revascularization 10 years The rate change of left ventricular ejection fraction 10 years Composite event of death, myocardial, stroke or repeat revascularization 10 years
Trial Locations
- Locations (19)
The Catholic University of Korea, Daejeon ST. Mary's Hospital
🇰🇷Daejeon, Korea, Republic of
Soon Chun Hyang University Hospital Cheonan
🇰🇷Cheonan, Korea, Republic of
Asan Medical Hospital
🇰🇷Seoul, Korea, Republic of
SAM hospital
🇰🇷Anyang, Korea, Republic of
Chonnam National University Hospital
🇰🇷Gwangju, Korea, Republic of
Soon Chun Hyang University Hospital Bucheon
🇰🇷Bucheon, Korea, Republic of
Chungbuk National University Hospital
🇰🇷Cheongju, Korea, Republic of
Gangwon National Univ. Hospital
🇰🇷Chuncheon, Korea, Republic of
Dong-A Medical Center
🇰🇷Pusan, Korea, Republic of
Gangneung Asan Hospital
🇰🇷Gangneung, Korea, Republic of
Bundang CHA Hospital
🇰🇷Seongnam, Korea, Republic of
ChonBuk National University Hospital
🇰🇷Jeonju, Korea, Republic of
Korea University Guro Hospital
🇰🇷Seoul, Korea, Republic of
The Catholic University of Korea Seoul St. Mary's Hospital
🇰🇷Seoul, Korea, Republic of
Wonju Severance Christian Hospital
🇰🇷Wonju, Korea, Republic of
Ulsan University Hospital
🇰🇷Ulsan, Korea, Republic of
Keimyung University Dongsan Medical Center
🇰🇷Daegu, Korea, Republic of
Chungnam National University Hospital
🇰🇷Daejeon, Korea, Republic of
Pusan National University Yangsan Hospital
🇰🇷Pusan, Korea, Republic of